Patent Assignment
Reel/Frame 070153/0736
Security Interest
Recorded: 2025-02-07
Pages: 13
Assignors
REVANCE THERAPEUTICS, INC.
Executed: 2025-02-06
BELLUS MEDICAL, LLC
Executed: 2025-02-06
CROWN LABORATORIES, INC.
Executed: 2025-02-06
Assignee
HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
65 DAVIES STREET, LONDON, W1K 5JL, UNITED KINGDOM
Covered Properties
(69)
Collagen Stimulation Device
Application:
63/709,952 →
Genetically Modified Bacteria and Methods for Genetic Modification of Bacteria
Application:
18/786,137 →
Publication:
US US20250002924A1
Methods and Systems for Point of Care Exosome Isolation
Application:
18/677,281 →
Publication:
US US20240398299A1
Probiotic Skin Formulations
Application:
18/804,339 →
Publication:
US US20250000787A1
Injectable Botulinum Toxin Formulations
Application:
17/951,220 →
Publication:
US US20240058628A1
Albumin-Free Botulinum Toxin Formulations
Application:
18/414,311 →
Publication:
US US20240382571A1
Methods and Kits for Topical Application, Removal, and Inactivation of Therapeutic or Cosmetic Toxin Compositions
Application:
17/114,486 →
Publication:
US US20210189326A1
Methods and Compositions for Treating Skin Conditions Associated With Vascular Hyper-reactivity
Application:
16/984,036 →
Publication:
US US20220347275A1
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
Application:
17/472,525 →
Publication:
US US20220062400A1
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/135,938 →
Publication:
US US20210252116A1
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
17/234,690 →
Publication:
US US20210308236A1
Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)
Application:
18/359,633 →
Publication:
US US20240000906A1
Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)
Application:
18/455,179 →
Publication:
US US20230390368A1
Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)
Application:
18/540,403 →
Publication:
US US20240108700A1
Methods of Treating an Optic Disease in a Subject
Application:
18/521,777 →
Publication:
US US20240100135A1
Transmucosal Botulinum Toxin Compositions, Kits, and Methods for Treating Bladder Disorders
Application:
18/973,057 →
Publication:
US US20250332232A1
Methods of Treatment for Cervical Dystonia
Injectable Botulinum Toxin Formulations and Methods of Use Thereof Having High Response Rate and Long Effect Duration
Application:
18/595,365 →
Publication:
US US20250064905A1
Injectable Botulinum Toxin Methods for Treating Headaches
Application:
17/912,513 →
Publication:
US US20230210963A1
Injectable Botulinum Toxin Methods for Treating Headaches
Application:
18/244,279 →
Publication:
US 2024/0216486
Methods for Treating Cervical Dystonia
Application:
18/031,861 →
Publication:
US US20240269246A1
Methods of and Compositions for Treatment of Upper Limb Spasticity
Application:
18/278,169 →
Publication:
US US20250268996A1
Compositions Comprising a Derivative of 5-Aminolevulinic Acid
Topical Anti-Pruritic Compositions and Methods of Action of Same
Genetically Modified Bacteria and Methods for Genetic Modification of Bacteria
Genetically Modified Bacteria and Methods for Genetic Modification of Bacteria
Collagen Stimulation Device and Methods
Skin Probiotic Formulation
Disposable Needle Cartridges Having Absorbing Contaminant Barriers
Patent:
9,636,491 →
Application:
15/176,223 →
Disposable Radio Frequency Needle Cartridges Having Absorbing Contaminant Barriers
Patent:
9,629,991 →
Application:
15/356,079 →
Radio Frequency Needling Device for Use with Disposable Needle Cartridges
Probiotic Skin Formulations
Needling Device for Use with Disposable Needle Cartridges
Arginine Heteromers for Topical Administration
Arginine Heteromers for Topical Administration
Compositions and Methods for Treating Acne
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Methods for Treating Pain by Topical Application and Transdermal Delivery of Botulinum Toxin
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Compositions and Methods for Topical Diagnostic and Therapeutic Transport
Compositions and methods for topical application and transdermal delivery of botulinum toxins
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Injectable Botulinum Toxin Formulations
Injectable Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Albumin-Free Botulinum Toxin Formulations
Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
Antimicrobial Peptide, Compositions, and Methods of Use
Compositions and Methods for Safe Treatment of Rhinitis
Composition for Therapeutic and Cosmetic Botulinum Toxin
Pharmaceutical Botulinum Toxin Compositions
Compositions, Methods and Devices for Preparing Less Painful Botulinum Toxin Formulations
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
Transmucosal Botulinum Toxin Compositions, Kits, and Methods for Treating Bladder Disorders
Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (Lip Ectropion)
Systems, Methods and Apparatus for Separating Components of a Sample
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 1, 2011
From: HELLAND, ODDVEIG SELLAEG; JOHNSEN, STIG OVE; ALABATA, ENRIQUE; JENTOFT, ANJA J.
To: PHOTOCURE ASA
Reel/Frame 026110/0793 →
Assignment of Assignor's Interest
Jul 9, 2012
From: GODAL, ASLAK
To: PHOTOCURE ASA
Reel/Frame 028560/0678 →
Assignment of Assignor's Interest
Sep 13, 2018
From: PHOTOCURE ASA
To: BELLUS MEDICAL, LLC
Reel/Frame 046871/0959 →
Patent Security Agreement
Nov 14, 2018
From: BELLUS MEDICAL, LLC
To: HAYFIN SERVICES LLP
Reel/Frame 047546/0499 →
Amended and Restated Patent Security Agreement
Dec 26, 2018
From: CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP
Reel/Frame 047983/0560 →
Assignment of Assignor's Interest
Jan 14, 2019
From: STIEFEL LABORATORIES INC.
To: CROWN LABORATORIES, INC.
Reel/Frame 047993/0666 →
Release of Security Interest
Sep 20, 2021
From: HAYFIN SERVICES LLP
To: BELLUS MEDICAL, LLC
Reel/Frame 057535/0264 →
Termination and Release of Amended and Restated Patent Security Interest
Sep 20, 2021
From: HAYFIN SERVICES LLP
To: CROWN LABORATORIES, INC.
Reel/Frame 057549/0760 →
Patent Security Agreement
Nov 17, 2021
From: CROWN LABORATORIES, INC.; NIADYNE, INC.; STRIVECTIN OPERATING COMPANY, INC.; BELLUS MEDICAL, LLC
To: HAYFIN SERVICES LLP
Reel/Frame 058175/0256 →
Security Interest
Dec 8, 2021
From: CROWN LABORATORES, INC.; BELLUS MEDICAL, LLC; STRIVECTIN OPERATING COMPANY, INC.; NIADYNE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058340/0600 →
Assignment of Assignor's Interest
Mar 16, 2022
From: RUEGG, CURTIS L.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059281/0037 →
Change of Name
Mar 17, 2022
From: ESSENTIA BIOSYSTEMS, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059435/0371 →
Employee Proprietary Information and Inventions Agreement
Mar 17, 2022
From: WAUGH, JACOB
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 059435/0362 →
Assignment of Assignor's Interest
Mar 18, 2022
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 059440/0061 →
Assignment of Assignor's Interest
Mar 18, 2022
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 059436/0236 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →
Assignment of Assignor's Interest
Jul 5, 2022
From: RUEGG, CURTIS L.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 060399/0215 →
Assignment of Assignor's Interest
Apr 17, 2023
From: RUBIO, ROMAN; NGUYEN-CLEARY, THAI; OH, CHAD
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 063350/0858 →
Assignment of Assignor's Interest
Jul 27, 2023
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 064401/0300 →
Assignment of Assignor's Interest
Jul 27, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 064401/0001 →
Assignment of Assignor's Interest
Aug 24, 2023
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 064712/0721 →
Assignment of Assignor's Interest
Aug 24, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 064712/0088 →
Assignment of Assignor's Interest
Oct 23, 2023
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 065317/0816 →
Assignment of Assignor's Interest
Oct 23, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 065317/0047 →
Assignment of Assignor's Interest
Nov 29, 2023
From: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 065708/0926 →